Ribon Company, Ltd. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Ribon Company, Ltd. has 0 FDA recalls, 2 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Ribon Company, Ltd., the most recent on Oct 5, 2015.

What these totals cover: FDA records filed under the name "Ribon Company, Ltd." and its spelling variant "Ribon Company".

Latest inspection
Feb 8, 2019 · NAI

Reviewing Ribon Company, Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Ribon Company, Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections2Nov 14, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Ribon Company, Ltd. FDA Warning Letters

1 warning letter on Oct 5, 2015.

IssuedSubjectIssuing officeClose-out letter
Oct 5, 2015

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent FDA inspections

2 inspections from Feb 20, 2015 to Feb 8, 2019.

DateSiteProductClassificationFEI
Feb 8, 2019Komaki, JapanFood/CosmeticsNo Action Indicated (NAI)3010493762
Feb 20, 2015Komaki, JapanFood/CosmeticsOfficial Action Indicated (OAI)3010493762
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Ribon Company, Ltd.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Oct 5, 2015.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3010493762Komaki, Japan2Feb 8, 2019

Ribon Company, Ltd. and the FDA: common questions

Has Ribon Company, Ltd. received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Ribon Company, Ltd.. The most recent is dated Oct 5, 2015.

Has Ribon Company, Ltd. received an FDA Form 483?

FDA has not published a Form 483 for "Ribon Company, Ltd." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Ribon Company, Ltd.?

The most recent FDA inspection on file ended Feb 8, 2019 at Komaki, Japan and was classified NAI. FDA has 2 inspections of Ribon Company, Ltd. on file, 1 of them classified OAI (official action indicated).

Need more than this page shows? Ask about Ribon Company, Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.